Related references
Note: Only part of the references are listed.Identification of Ligand-Induced Proteolytic Cleavage and Ectodomain Shedding of VEGFR-1/FLT1 in Leukemic Cancer Cells
Nader Rahimi et al.
CANCER RESEARCH (2009)
A Compartment Model of VEGF Distribution in Humans in the Presence of Soluble VEGF Receptor-1 Acting as a Ligand Trap
Florence T. H. Wu et al.
PLOS ONE (2009)
A compartment model of VEGF distribution in blood, healthy and diseased tissues
Marianne O. Stefanini et al.
BMC SYSTEMS BIOLOGY (2008)
A novel human-specific soluble vascular endothelial growth factor receptor 1 - Cell type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia
Shay Sela et al.
CIRCULATION RESEARCH (2008)
Circulating vascular endothelial growth factor and its soluble receptors in patients with liver cirrhosis: Possible association with hepatic function impairment
Jerzy Jaroszewicz et al.
CYTOKINE (2008)
A VEGF trap inhibits the beneficial effect of bFGF on vasoreactivity in corporal tissues of hypercholesterolemic rabbits
Donghua Xie et al.
JOURNAL OF SEXUAL MEDICINE (2008)
Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease
Clarence M. Findley et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Systems Biology of Vascular Endothelial Growth Factors
Feilim Mac Gabhann et al.
MICROCIRCULATION (2008)
Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer
Yu-Ting Chang et al.
PANCREAS (2008)
A prospective, observational study of soluble FLT-1 and vascular endothelial growth factor in sepsis
Nathan I. Shapiro et al.
SHOCK (2008)
Metastasis: the seed and soil theory gains identity
Emmanouil Fokas et al.
CANCER AND METASTASIS REVIEWS (2007)
Impaired angiogenesis after Hindlimb ischemia in type 2 diabetes Mellitus - Differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1
Surovi Hazarika et al.
CIRCULATION RESEARCH (2007)
Soluble fms-like tyrosine kinase-1 expression inhibits the growth of multiple myeloma in nude mice
Junru Liu et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2007)
Alternative splicing in angiogenesis: The vascular endothelial growth factor paradigm
Michael R. Ladomery et al.
CANCER LETTERS (2007)
Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier
Balamurali K. Ambati et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2007)
Vascular endothelial growth factors -: Biology and current status of clinical applications in cardiovascular medicine
Seppo Yla-Herttuala et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Mapping the theories of preeclampsia and the role of angiogenic factors - A systematic review
Mariana Widmer et al.
OBSTETRICS AND GYNECOLOGY (2007)
Interactions of VEGF isoforms with VEGFR-1, VEGFR-2, and neuropilin in vivo: a computational model of human skeletal muscle
Feilim Mac Gabhann et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Release of soluble vascular endothelial growth factor receptor-1 (sFlt-1) during coronary artery bypass surgery
Yves Denizot et al.
JOURNAL OF CARDIOTHORACIC SURGERY (2007)
VEGF receptor signalling - in control of vascular function
AK Olsson et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
The role of VEGF receptors in angiogenesis;: complex partnerships
S Cébe-Suarez et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1 (Withdrawn Publication. See vol. 298, 2021)
J Cai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
VEGF-A splice variants and related receptor expression in human skeletal muscle following submaximal exercise
T Gustafsson et al.
JOURNAL OF APPLIED PHYSIOLOGY (2005)
Suppression of tumor growth by oncolytic adenovirus-mediated delivery of an antiangiogenic gene, soluble Flt-1
ZL Zhang et al.
MOLECULAR THERAPY (2005)
Soluble VEGF/sFLt1 ratio is an independent predictor of AML patient out come
S Aref et al.
HEMATOLOGY (2005)
The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications
K Podar et al.
BLOOD (2005)
Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer
H Bando et al.
BRITISH JOURNAL OF CANCER (2005)
The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions
H Takahashi et al.
CLINICAL SCIENCE (2005)
sFlt-1 gene therapy of follicular thyroid carcinoma
CS Ye et al.
ENDOCRINOLOGY (2004)
Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia
S Ahmad et al.
CIRCULATION RESEARCH (2004)
Internal and external autocrine VEGF/KDR loops regulate survival of subsets of acute leukemia through distinct signaling pathways
SCR Santos et al.
BLOOD (2004)
Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis
J Miotla et al.
LABORATORY INVESTIGATION (2000)
Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids
C Hornig et al.
LABORATORY INVESTIGATION (2000)
Share Paper
